Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah L Mason

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of Feline Medicine and Surgery|February 7, 2022
Use of a cyclical hypofractionated radiotherapy regime ('QUAD shot') for the treatment of feline sinonasal carcinomasPetros S Frezoulis, Aaron Harper, Sarah L Mason
Frontiers in Veterinary Science|June 20, 2022
Case Report: A Novel Lateral Approach to the C7, C8, and T1 Intervertebral Foramina for Resection of Malignant Peripheral Nerve Sheath Neoplasia, Followed by Adjunctive Radiotherapy, in Three DogsOliver Marsh, Naomi Shimizu, Sarah L Mason, et al.
Oncogene|June 26, 2002
p14(ARF) regulates E2F activitySarah L Mason, Oonagh Loughran, Nicholas B La Thangue
Progress in Brain Research|December 1, 2012
Current status of clinical trials of neural transplantation in Parkinson's diseaseJonathan R Evans, Sarah L Mason, Roger A Barker
Journal of Neurology|February 15, 2022
Exploring the predictors of financial impairment in Huntington's disease using the Enroll-HD datasetKate L Harris, Sarah L Mason, Roger A Barker
Neurorehabilitation|February 11, 2020
Parkinson's disease and spiritualityClare Redfern, Sarah L Mason, Roger A Barker, et al.
The Lancet. Neurology|December 15, 2012
Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's diseaseRoger A Barker, Jessica Barrett, Sarah L Mason, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 3, 2016
Hippocampal dysfunction defines disease onset in Huntington's diseaseFaye Begeti, Laetitia C Schwab, Sarah L Mason, et al.
The Veterinary Record|July 23, 2021
Should we be discouraging use of 'anticancer' supplements in dogs and cats with cancer?Antonio Giuliano, Sarah L Mason, James Elliott, et al.
Neuroscience Letters|October 12, 2021
Reduced expression of dopamine D2 receptors on astrocytes in R6/1 HD mice and HD post-mortem tissueKate L Harris, Sarah L Mason, Benjamin Vallin, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of Feline Medicine and Surgery|February 7, 2022
Use of a cyclical hypofractionated radiotherapy regime ('QUAD shot') for the treatment of feline sinonasal carcinomasPetros S Frezoulis, Aaron Harper, Sarah L Mason
Frontiers in Veterinary Science|June 20, 2022
Case Report: A Novel Lateral Approach to the C7, C8, and T1 Intervertebral Foramina for Resection of Malignant Peripheral Nerve Sheath Neoplasia, Followed by Adjunctive Radiotherapy, in Three DogsOliver Marsh, Naomi Shimizu, Sarah L Mason, et al.
Oncogene|June 26, 2002
p14(ARF) regulates E2F activitySarah L Mason, Oonagh Loughran, Nicholas B La Thangue
Progress in Brain Research|December 1, 2012
Current status of clinical trials of neural transplantation in Parkinson's diseaseJonathan R Evans, Sarah L Mason, Roger A Barker
Journal of Neurology|February 15, 2022
Exploring the predictors of financial impairment in Huntington's disease using the Enroll-HD datasetKate L Harris, Sarah L Mason, Roger A Barker
Neurorehabilitation|February 11, 2020
Parkinson's disease and spiritualityClare Redfern, Sarah L Mason, Roger A Barker, et al.
The Lancet. Neurology|December 15, 2012
Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's diseaseRoger A Barker, Jessica Barrett, Sarah L Mason, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 3, 2016
Hippocampal dysfunction defines disease onset in Huntington's diseaseFaye Begeti, Laetitia C Schwab, Sarah L Mason, et al.
The Veterinary Record|July 23, 2021
Should we be discouraging use of 'anticancer' supplements in dogs and cats with cancer?Antonio Giuliano, Sarah L Mason, James Elliott, et al.
Neuroscience Letters|October 12, 2021
Reduced expression of dopamine D2 receptors on astrocytes in R6/1 HD mice and HD post-mortem tissueKate L Harris, Sarah L Mason, Benjamin Vallin, et al.
Pageof 6